20VC: Hims & Hers: $4.3BN Market Cap on $2.3BN of Revenue: The Comeback | Why Being Public is 10x Better | The Death of the "Strategy" Hire | Why Performance Marketing is Worse than Brand Marketing with Andrew Dudum

What It Covers

Hims & Hers CEO Andrew Dudum covers building a $4.3B market cap company on $2.3B revenue, explaining why public markets outperform private, how to hire for grit over credentials, why brand marketing requires consistency over campaigns, and how Hims plans to verticalize preventative healthcare diagnostics.

Key Questions Answered

• •Hiring for grit over credentials: Avoid the "strategy hire" trap as companies scale. Dudum deliberately recruits leaders who navigated crises — his CFO managed Uber during COVID when revenue vanished overnight, his CPO handled Robinhood during GameStop chaos. Operators who have survived disruption perform better than credentialed executives from prestigious companies when building in chaotic, fast-moving categories.
• •Replace yourself every 12 months: CEOs must continuously hire people smarter than themselves in each function, then elevate their own focus to the next highest-leverage area. Managers who fear hiring superior talent stall organizational growth. The goal is identifying two or three critical areas requiring deep personal involvement while trusting stronger hires to own everything else independently.
• •Brand marketing requires consistent repetition, not campaigns: One-off out-of-home activations generate excitement internally but produce no measurable business impact. Effective brand marketing requires appearing across multiple channels repeatedly — consumers need roughly 10 distinct exposures before brand trust elevates. Companies also make the mistake of changing their core message when they grow bored of it, destroying brand recognition before audiences absorb it.
• •Build a loss-leader diagnostic front door: Hims acquired a home blood collection device costing a few dollars to manufacture, enabling 50-biomarker panels including genetic predisposition markers like lipoprotein(a). The strategy is offering this testing at or near zero cost as a membership benefit, using verticalized lab infrastructure to reduce costs, then converting informed patients into long-term treatment customers across multiple clinical categories.
• •Portfolio management over single-category focus: Hims operates roughly a dozen distinct clinical categories — ED, hair loss, weight loss, mental health, peptides — each treated as a separate venture bet. High-performing categories receive more funding; underperformers get starved. This structure creates revenue durability because no single category dominates, and new categories like peptides are entered only when clinical protocols and supply chain quality meet internal standards.